Agora Financial Offering Financial Information You Can Trust


Agora Financial is one of the leading names in the world of economic publications and has a variety of publications, including newsletters, ebooks, magazines, videos, and more. Agora Financial was built with the mission to educate the people about the financial market and help people make wise choices with their money. As the economic market continues to stay volatile and the amount of options in the investment scene continues to multiply, it is essential for the people these days to rely on some expert advice. It is what Agora Financial offers its customers, who are looking to invest their money to achieve their long term financial goals.

Bill Bonner started Agora Financial in the year 1979 to help people get the financial insight they need to make smart investment decisions. As the market is filled with a variety of investment products, starting from mutual funds to equity market and from retirement plans to precious metals, and more, it has become difficult for the people to choose which investment option to select as per their financial goals and objectives. Agora Financial offers reliable and expert investment and financial advice in simple and easy to understand language so that people can make smart investment choices and avoid making common mistakes.

Agora Financial invests over a million dollar each year on only the travel expense of its reporters and employees who penetrate different sectors to find out what is going on in various industries. It helps in knowing whether the sector is worth investing in or not. Agora Financial has made some remarkable predictions in the last few years, which has helped save its over a million subscribers, a substantial amount of money. Agora Financial takes pride in the fact that it offers non-biased reporting and doesn’t accept money from any company or organization to mislead its readers.

To Learn More :

Global Companies Help Open New Oil Drill in Mexico


For almost 80 years, the country of Mexico has wanted international competitors to become involved in its local energy markets and its wish came true this year when a private firm created a new offshore oil well in the waters of Mexico.

This construction of an offshore oil well was able to be done through the efforts of these companies: Premiere Oil, Talos Energy and Sierra Oil, the only local Mexican company among this group.

Premier Oil was the firm that announced that this happened. Premier was the first company to be able to do since the Mexican government nationalized oil in 1938 and created the oil monopoly called Petroleos.

This new oil well has been called Zama-1 and can now be found in the Sureste Basin off the coast of the Mexican state of Tabasco. In the future, Premier predicts hat the oil well should hold about 100 to 500 million barrels of oil. The drilling will take 95.0 days to finish and will cost about 16 million US dollars. The three global companies involved in this new oil well won the first round of bidding in 2015.

Elaine Reyn, an Edison Investment Research analyst in London, believes that Zama is the first Pemex well to be created due to the energy reform process of Mexico. She expects that the international oil industry is very curious to see what happens with this new effort. She is betting that geologically, this drilling has a very good chance of success.

When Zama is finished, Charlie Sharp of Canaccord Genuity sees this drilling as one of the most captivating explorations for 2017.

The stakes of the new well have been determined. Talos will have a stake of 35 percent in the well while Sierra will have 40%. Premier will get the remaining stake of 25%.

Talos Energy, one of the companies that is part of this new drill, was started with 600 million US dollars that it got from equity In one day, it can produce 16,000 barrels of oil in the Gulf of Mexico. 60 professionals operate this company in Houston Texas. If a person counts the field operators for this company along the Gulf Coast, a person should find that there are 120 employees.

Talos Energy proud to acknowledge that Workplace Dynamics the best w acorkplace among local businesses. They were able to get this acknowledgement without having to do Friday happy hours or have day care centers onsite.

Visit More :

José Auriemo Neto’s Stunning Innovation Skills


The constant growth in the real estate field has drawn many realtors to invest their time, effort and money into the sector. With many successful business men in the same venture, José Auriemo Neto sought a creative way to bring something more appealing to the table. Having run a parking lot management company in his early years at the company, Neto based his emphasis on commercial properties. He has since developed entrepreneurial platforms to strengthen the business.


Neto has worked in JHSF for many years alongside his father. He gained more experience and later rose to being chairman and chief executive officer of the company. Since he took over in 2003 José Auriemo Neto has added many achievements to the company’s portfolio including luxury hotels, shopping malls and being the first real estate company to build a free apartment. The company has a shopping and retail portfolio that includes a variety of shopping centers and in different parts of Brazil. Neto also saw the company through its first venture into retail with partnership with renowned designers in the fashion industry like Louis Vuitton, Hermes and Pucci. Valentino also partnered with the company and launched their stores in Brazil. There are multiple properties that have been acquired by the company that has fast dominated the world of real estate. This is all attributed to the leadership and hard work of José Auriemo.


José Auriemo Neto went to Fundacao Armando Alvares Penteado University in Sao Paulo. He started working with the company back in 1993 and was the pioneer of the company’s service department by founding a parking lot management company which after much success later developed into a shopping centre department. This is after he obtained the rights. Neto understands the roles of a leader in his level and more developed levels like senior management.

Learn Mre Click Here

Amicus Therapeutics And Their Growing Business


Amicus Therapeutics is one of the fastest-growing pharmaceutical companies in the world, and they are building better medications for patients and customers who will use them for a number of diseases. The company has built a robust business, and this article explains how they are growing in the field of bio pharmaceuticals. There are many bio medications that may be researched and produced through this company, and they will ensure that the patients who use their medications have better results in the future.

#1: They Research Many Drugs

There are many drugs that are produced by this company every day, and they are working on products that will be sent to doctors for trial. They have many partners in the field who are giving trial medications to their patients. They are participating in initial trials and studies that will ensure patients have better results. The results that have been seen further help the company progress.

#2: They Produce New Drugs

There are many drugs that come from the company every year, and they are increases sales through their new drug releases. It is quite important for someone who wishes to recover from a particular disorder to have contacted Amicus Pharmaceuticals. Someone who is searching for a better medication may contact Amicus for help.

#3: They Are Emplying More People

The company is growing their workforce many times over because they must hire more people to create their medications. It is quite simple for people who are new to the business to start with Amicus, and they will be a part of a company that is growing more every year. Amicus has shown great returns on their investments in medications, and they have proven that their research produces new medications.

The newest medications in the industry are coming from a company such as Amicus Pharmaceuticals. The company will continue to grow and research the medications that will serve the doctors and nurses who participate in their trials.